Home › Funds › Opaleye Management Inc. › ENTA
Opaleye Management Inc. position in ENTA
ENANTA PHARMACEUTICALS INC COM · Health Care
Opaleye Management Inc. reported holding 125,000 shares of ENTA (ENANTA PHARMACEUTICALS INC COM) in its Q2 2026 13F filing — a position valued at US$1.8M, representing 0.17% of its reported portfolio and ranking #48 among its reported holdings. Opaleye Management Inc. has disclosed ENTA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Opaleye Management Inc.'s ENTA position evolved
Opaleye Management Inc. first disclosed a stake in ENTA in Q4 2025 at 75,000 shares (US$1.2M). The position peaked in Q2 2026 at 125,000 shares, worth US$1.8M. Across 3 filings, Opaleye Management Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 125,000 shares valued at US$1.8M. Notable position changes include a 67% increase in Q1 2026 (shares rose 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 75.00K | $1.18M | New |
| Q1 2026 | 125.00K | $1.58M | Add |
| Q2 2026 | 125.00K | $1.82M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ENTA and 13F data
ENTA (ENANTA PHARMACEUTICALS INC COM) is a Health Care company. 29 other funds we track also report a position in ENTA — the largest reported positions include Krensavage Asset Management, LLC (US$41.8M), Farallon Capital Management (US$35.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$35.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENTA
- Krensavage Asset Management, LLC 2.87M sh · $41.79M · Q2 2026
- Farallon Capital Management 2.42M sh · $35.26M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.42M sh · $35.26M · Q2 2026
- ADAR1 Capital Management, LLC 1.34M sh · $19.60M · Q2 2026
- Spruce Street Capital LP 1.09M sh · $15.87M · Q2 2026
More on Opaleye Management Inc.
FAQ
How long has Opaleye Management Inc. held ENTA?
Opaleye Management Inc. has disclosed ENTA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Opaleye Management Inc.'s current position in ENTA?
As of Q2 2026, Opaleye Management Inc. holds 125.00K shares of ENTA (ENANTA PHARMACEUTICALS INC COM), valued at $1.82M, representing 0.17% of its reported portfolio and ranking #48.
Has Opaleye Management Inc. been buying or selling ENTA?
In the latest 13F filing (Q2 2026), Opaleye Management Inc. held unchanged its position in ENTA. The position peaked in Q2 2026 at 125.00K shares.
Which other funds hold ENTA?
Other major institutional holders of ENTA include Krensavage Asset Management, LLC, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.